Bilateral Ovarian Teratoma with Carcinosarcoma in a 68-Year-Old Woman
Author Information
Author(s): Shanmughapriya S, SenthilKumar G, Balakrishnan K, Vasanthi N, Vinodhini K, Natarajaseenivasan K
Primary Institution: Bharathidasan University
Hypothesis
The study aims to determine the impact and success of neoadjuvant chemotherapy and interval cytoreduction in treating ovarian teratoma in older women.
Conclusion
Neoadjuvant chemotherapy followed by interval cytoreduction can improve treatment outcomes for older women with advanced ovarian cancer.
Supporting Evidence
- The patient was diagnosed with FIGO stage IIIC.
- Neoadjuvant chemotherapy was administered before surgery.
- Post-operative follow-up showed no evidence of recurrence.
Takeaway
This study is about a 68-year-old woman who had a rare type of ovarian tumor. Doctors used special treatments to help her, and she did not have any more cancer after surgery.
Methodology
The patient underwent neoadjuvant chemotherapy followed by interval cytoreductive surgery.
Limitations
The study is based on a single case report, which may limit the generalizability of the findings.
Participant Demographics
The patient was a 68-year-old woman with a history of hypertension and diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website